Best Defense Is Good Offense: PhRMA Wants PBMs To 'Share The Savings'
PhRMA ad campaign targets US payer practice of using drug rebate dollars for general premium and cost sharing reductions and not to lower the cost of specific prescription fills.
You may also be interested in...
Biggest benefit to manufacturers from the insurer's upcoming program may be relieving public pressure on list prices.
Express Scripts CEO Timothy Wentworth and PhRMA President Steven Ubl discussed some of the issues around drug rebating practices at the Forbes Healthcare Summit, including point-of-sale rebates.
Analysis funded by Pharmaceutical Care Management Association concludes that using drug rebates to lower beneficiary cost sharing at the point-of-sale would raise premiums and increase government spending.